The new strategy of tissue engineering, and regenerative medicine at large, is to construct biomimetic matrices to mimic nature's hierarchical structural assemblages and mechanisms of simplicity and elegance that are conserved throughout genera and species. There is a direct spatial and temporal relationship of morphologic and molecular events that emphasize the biomimetism of the remodeling cycles of the osteonic corticocancellous bone versus the ''geometric induction of bone formation,'' that is, the induction of bone by ''smart'' concavities assembled in biomimetic matrices of macroporous calcium phosphateYbased constructs. The basic multicellular unit of the corticocancellous bone excavates a trench across the bone surface, leaving in its wake a hemiosteon rather than an osteon, that is, a trench with cross-sectional geometric cues of concavities after cyclic episodes of osteoclastogenesis, eventually leading to osteogenesis. The concavities per se are geometric regulators of growth-inducing angiogenesis and osteogenesis as in the remodeling processes of the corticocancellous bone. The concavities act as a powerful geometric attractant for myoblastic/myoendothelial and/or endothelial/pericytic stem cells, which differentiate into bone-forming cells. The lacunae, pits, and concavities cut by osteoclastogenesis within the biomimetic matrices are the driving morphogenetic cues that induce bone formation in a continuum of sequential phases of resorption/dissolution and formation. To induce the cascade of bone differentiation, the soluble osteogenic molecular signals of the transforming growth factor A supergene family must be reconstituted with an insoluble signal or substratum that triggers the bone differentiation cascade. By carving a series of repetitive concavities into solid and/or macroporous biomimetic matrices of highly crystalline hydroxyapatite or biphasic hydroxyapatite/A-tricalcium phosphate, we were able to embed smart biologic functions within intelligent scaffolds for tissue engineering of bone. The concavities assembled in the bioceramic constructs biomimetize the remodeling cycle of the corticocancellous bone and are endowed with multifunctional pleiotropic self-assembly capacities, initiating angiogenesis and bone formation by induction without the exogenous applications of the osteogenic-soluble molecular signals of the transforming growth factor A supergene family. The incorporation of specific biologic activities into biomimetic matrices by manipulating the geometry of the substratum, defined as geometric induction of bone formation, is now helping to engineer therapeutic osteogenesis in clinical contexts.
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BIOMIMETISM AND THE TISSUE ENGINEERING PARADIGM
The enduring quest by surgeons to rehabilitate ever more complex deficits of the human skeleton is driving the search for a regenerative methodology unencumbered by the problems of autologous bone grafting. The hint of promise unveiled by the earliest work on bone autoinduction captured the imagination of clinicians and scientists who dreamed of finally endowing clinicians with a technically simple treatment for bone defects in humans by controlling and therapeutically deploying the ''bone induction principle.'' The great strides made in the last 5 decades unlocked several of the mysteries of autoinduction to the extent that only 2 decades ago many basic scientists were confidently but prematurely stating that the problem of bone regeneration in humans had been solved. Yet, this dream remains unfulfilled, as more and more substandard clinical outcomes following the use of bone tissue engineering unmistakably reveal our lack of understanding of a process we all thought had been well understood.
The basic tissue engineering paradigm is tissue induction and morphogenesis by combinatorial molecular protocols whereby soluble molecular signals are combined with insoluble signals or substrata acting as three-dimensional scaffolds for the initiation of de novo tissue induction and morphogenesis. 1Y3 There is no bone formation by induction without the osteogenic proteins (OPs) of the transforming growth factor A (TGF-A) superfamily. 4 Bone tissue engineering starts by erecting scaffolds of biomimetic matrices that control the expression of the osteogenic-soluble molecular signals of the TGF-A superfamily. 5, 6 The molecular scaffolding lies at the heart of all new tissue engineering strategies. 5Y7 Recently, the lexicon of regenerative medicine and tissue engineering has been enriched by the introduction of the term ''biomimetism.'' Biomimetism is the creative initiation of various specific biologic systems gaining inspiration from nature. 8Y11 A question that the senior author has asked after several years of research into the induction of bone formation has always been: Can we engineer biomimetic matrices that in its own right can direct cell differentiation and expression of selected mRNA species of the TGF-A superfamily without the exogenous applications of OPs, 6, 12 that is, a macroporous device that per se even if implanted in heterotopic intramuscular sites will generate new bone by induction constructing large ossicles for surgical transplantation even without the exogenous application of the OPs of the TGF-A supergene family?
The concavities created in sintered highly crystalline HAs and/or biphasic HA/A-tricalcium phosphate (A-TCP) bioceramics when implanted in heterotopic intramuscular sites of the nonhuman primate Papio ursinus set into motion a ripple-like cascade of cellular differentiation. 6, 7, 12, 13 Invading myoblastic/myoendothelial and/or endothelial/pericytic stem cells differentiate into osteoblasticlike cells, expressing and secreting osteogenic gene products, which later become embedded into the concavities of the biomimetic matrices 6,12Y17 initiating the induction of bone formation as a secondary response.
The new strategy to initiate the induction of bone formation is to carve ''smart'' self-inducing geometric cues assembled within biomimetic matrices.
14,17Y19 The concavities are endowed with the striking prerogative of differentiating myoblastic/myoendothelial and/or endothelial/pericytic stem cells into osteoblastic-like cells secreting osteogenic molecular signals further differentiating invading mesenchymal stem cells initiating bone formation by induction as a secondary response.
12,17Y21 Systematic studies in the nonhuman primate (P. ursinus) have shown that the driving force of the intrinsic induction of bone formation by bioactive biomimetic matrices is the shape of the implanted scaffold 12, 14, 19 ; the language of shape is the language of geometry; the language of geometry is a sequence of repetitive concavities that biomimetizes the remodeling cycle of the primate osteonic bone. 17Y21 The remodeling cycle of the corticocancellous bone entails ''resting'' periods with quiescent resting cells over trabeculae of bone, ''activation,'' whereby activated osteoclasts resorb mineralized bone, and ''formation,'' whereby differentiating osteoblasts appear in the lacunae and pits inducing bone deposition within the concavities cut by osteoclastogenesis. 13, 22, 23 For comparative purposes, a fully developed corticocancellous remodeling unit, or basic multicellular unit (BMU), 22, 23 is an elongated cylindrical structure that burrows through bone, in a direction generally aligned with the long axis of the bone. 22, 23 A BMU travels across the surface of the cancellous cone cutting a trench rather than a tunnel across its surface, 22, 23 that is, a groove with geometric cues of concavities at different stages of osteoclastogenesis. 19 There is thus a direct spatial and temporal biomimetism of morphologic and molecular events that emphasizes the similarities between the remodeling cycle of the corticocancellous bone and the ''geometric induction of bone formation'' by smart concavities cut into calcium phosphateYbased biomimetic matrices.
Quoting the discussion of Parfitt et al 22 on osteonal remodeling and signal trafficking in the corticocancellous bone, ''a mechanism is needed to ensure that osteoblasts follow osteoclastic bone resorption.'' The BMU, in Frost's 23 terminology, is a complex and unique structure responsible for osteonal remodeling comprising a cutting cone of osteoclasts in front and a closing cone lined by osteoblasts with connective tissue and blood vessels filling the cavity. 22, 23 The positional information needed to control the direction of advancement of a BMU is unknown 22 ; that is, the resorption phase followed by the formation phase, although expressed and secreted molecular signals, is a very plausible notion. 22 Our morphologic observations on the ''spontaneous'' induction of bone formation by precut concavities into calcium phosphateYbased biomimetic matrices have proposed the geometric cue of the concavity as an additional driving signal for the induction of bone formation. 19, 21 Thus, the initiation of bone within concavities of the smart biomimetic constructs biomimetizes the remodeling cycle of the bone unit, also defined as ''osteosome. '' 24 This is via a continuum of resorption and bone deposition initiated by the concavities in the form of resorption lacunae and pits cut by osteoclastogenesis and used for the deposition of bone by induction. 19, 21 There is thus a continuum between the solid states of the newly formed bone as in the skeleton in which the continuum is regulated by signals in solution interacting with the insoluble extracellular matrix. 24 Selfinducing biomimetic matrices or insoluble signals regulate the expression of the osteogenic-soluble molecular signals initiating the ripple-like cascade of bone differentiation by induction. 12, 19, 21 The lacunae and concavities cut by osteoclastogenesis within the biomimetic matrices are the driving morphogenetic cues to induce bone formation in a continuum of sequential phases of resorption/ dissolution and induction of bone formation. 19, 21 The concavities assembled in the biomimetic matrices biomimetize the remodeling cycle of the primate corticocancellous bone and are endowed with multifunctional pleiotropic self-assembly capacities initiating angiogenesis and bone formation by induction.
19Y21

THE INDUCTION OF BONE FORMATIONVTHE OSTEOGENIC PROTEINS OF THE TGF-A SUPERGENE FAMILY
Tissue engineering proposes to formulate and to construct biologic substitutes for human tissue and organ replacement, that is, living replacing parts for the human body.
1Y3 Advances in the field of molecular and cellular biology have made possible the mechanistic understanding of tissue induction and morphogenesis 3Y7 ; the development of engineered tissues is a logical step forward in the ongoing effort to improve and to gain the mechanistic understanding of tissue biology and experimental reconstructive surgery for human tissue regeneration. 25 Within the biomedical concept of regenerative medicine, the term tissue engineering points naturally to a central concept that is simple, powerful, and intuitive, that is, the creation of living tissues for therapeutic regenerative purposes. 25 The origin of the term tissue engineering has been traced to YC Fung of the University of California San Diego, who submitted an unsuccessful proposal to the National Science Foundation in 1985 under the title ''Center for the Engineering of Living Tissue.'' 25 In the following years, a number of researchers were responsible for developing the concept and the nature of tissue engineering as well as for developing and rapidly expanding this enabling technology into prototype tissueengineered solutions applicable to several tissues and organs of the mammalian body. 1Y3,25,26 Tissue induction and morphogenesis require 3 key components 5, 27 : a morphogenetic soluble signal, an insoluble signal or substratum, and responding hosts' stem cells. The basic tissue engineering paradigm is tissue and organ development engineered by combinatorial molecular protocols. 1Y3,5,27 The induction of bone formation, by combining soluble osteogenic molecular signals with insoluble signals or substrata, is the essence of the tissue engineering paradigm. 1, 3, 5, 6, 20 Soluble molecular signals are combined and reconstituted with insoluble signals or substrata that act as threedimensional scaffolds for the initiation of de novo tissue induction and morphogenesis. 1,5,20,27Y30 The rationale of linking the induction of tissue morphogenesis to ''bone formation by autoinduction'' 31 is based on the discovery of the pleiotropic activity of the osteogenic-soluble molecular
Ripamonti et al
The Journal of Craniofacial Surgery & Volume 22, Number 5, September 2011 signals of the TGF-A supergene family. 5, 6 Soluble molecular signals are endowed with the striking prerogative of initiating the induction of bone formation as well as tissue patterning and morphogenesis of several disparate tissues and organs including, but not limited to, the root cementum, the root dentin, the kidney, and the skin. 5, 6 Indeed, bone morphogenetic proteins (BMPs) have now been labeled as body morphogenetic proteins, rather than the more limiting term of bone morphogenetic proteins.
32
Landmark conceptual developments as a program for the evolving concept of tissue engineering have emerged after critical discoveries in the field of bone development and morphogenesis. 4Y7,25 The induction of bone tissue formation has evolved as a prototype of the tissue engineering paradigm continuously developing the concept and further expanding the depth and the breadth of the novel biologic and surgical concept. 5, 19, 21, 25, 32 Following major breakthroughs in the understanding of the sequential cascade of bone formation by autoinduction, 31 the bone induction principle 33Y35 was translated in clinical contexts first by using naturally derived, highly purified BMPs/OPs 36Y39 and later by using human recombinant proteins in preclinical 40 and clinical contexts. 41, 42 The induction of bone formation 31, 43, 44 initiates by invocation of soluble molecular signals that, when combined with insoluble signals or substrata, trigger the ripple-like cascade of bone differentiation. 5, 6 The osteogenic-soluble molecular signals of the TGF-A supergene family, the BMPs/OPs, and uniquely in primates the 3 mammalian TGF-A isoforms per se induce endochondral bone formation as a recapitulation of embryonic development. 6, 16, 45, 46 Intramuscular and subcutaneous implantation of demineralized bone matrices results in bone formation by induction. 31, 43, 44 Mineralized matrices of bone (and dentin) must thus contain signaling molecules (or ''morphogens''), first defined by Turing as forms generating substances, that control tissue patterning and morphogenesis. 47 Morphogens are capable of initiating differentiating pathways in responding stem cells after interaction with specific cell surface receptors, initiating pattern formation and the generation of bone with hematopoietic bone marrow. 5, 6, 40, 48 How are the morphogens responsible for the induction of bone formation accessed and isolated? The biochemical problem of the putative OPs tightly bound to the extracellular matrix of bone was overcome by the dissociative extraction and reconstitution of the bone-inductive components from the demineralized bone matrix with chaotropic agents. 1 This critical experiment showed that the intact and biologically active demineralized bone matrix could yield solubilized proteins and a residual inactive mainly insoluble collagenous bone matrix. 1 Importantly for tissue engineering strategies in preclinical and clinical contexts, neither the solubilized proteins nor the insoluble residues were active 1, 29 ; however, a reconstitution of the soluble and insoluble components restored the osteogenic activity in the extraskeletal heterotopic bioassay. 1, 5, 29, 30 The operational reconstitution of the soluble signal with an insoluble signal or substratum was a key experiment that provided a bioassay for bona fide initiators of endochondral bone differentiation, 1, 27 which has driven the bone induction principle 33 in preclinical and clinical contexts. 4Y6,41,42 It was noteworthy that the induction of bone formation in the rodent heterotopic assay was also possible after the reconstitution of rat insoluble collagenous matrix with solubilized OPs of different mammalian species. 29 These classic experiments implied that there are homologies between bone-inductive proteins from human, baboon, monkey, bovine, and rat extracellular matrices 29 and set into motion the race for the purification of an entirely new family of proteins initiators collectively called BMPs/OPs. Bone morphogenetic proteins/OPs belong to the TGF-A supergene family. 5, 6, 40 The classic experiments of Sampath and Reddi 1,29 also highlighted the critical role of recombining or reconstituting the osteogenic-soluble molecular signal with an insoluble signal or substratum to trigger the bone induction cascade.
5,27Y30
The osteogenic-soluble molecular signals of the TGF-A supergene family, the BMPs/OPs, and uniquely in primates the 3 mammalian TGF-A isoforms 49Y52 induce endochondral bone as a recapitulation of embryonic development. 5, 6 Preclinical trials in several animal species including the nonhuman primate (P. ursinus) with naturally derived, highly purified BMPs/OPs or recombinant human OP-1 (hOP-1) and human BMP-2 (hBMP-2) have confirmed the expected theoretical potential to regenerate bone. 6 However, the translation of these results in human patients has proven to be surprisingly difficult, with only small volumes of bone induced by megadoses of recombinant human proteins, several folds higher than the dosage predicted in animal models including nonhuman primates. 53Y55 In his classic editorial comment entitled the ''The Reality of a Nebulous Enigmatic Myth,'' 56 Marshall Urist 33 stated that preclinical research and clinical research on the bone induction principle ''are bound to dispel the myth and appreciate the reality of bone induction for the benefit of patients with crippling diseases of the bone and joints.'' Forty years later, the Bone Research Laboratory, not in Los Angeles but in Johannesburg, still feels ''The Reality of a Nebulous Enigmatic Myth'' when reading that several tens of milligrams of a recombinant hBMP/hOP are needed to induce an uninspiring bone volume in human patients. 41 ,42,57Y59 Human bone regeneration has proven to be an elusive target when compared with results obtained in preclinical studies including nonhuman primate species. 46 The induction of bone has dramatically shown that regenerative medicine in clinical contexts is on a different scale altogether when compared with animal models that may not adequately translate and reproduce morphogen-related therapeutic responses in Homo sapiens; indeed, focused research experiments should be now devoted to systematically identify differences in the healing patterns among mammals.
Whereas reconstructive surgery has been profoundly simplified, the biology of the bone induction cascade has proven to be far more complex than we could ever imagine. It is patent that the philosophy of deploying a single recombinant morphogen to address any defect of the human skeleton is no longer driven by evidence but expediency. These unpleasant facts will not disappear if we continue to ignore them; it will require tenacity and renewed vigor to search for an alternative route to the promise tentatively alluded to more than 5 decades ago. 31,33Y36,56 The ultimate therapeutic strategies to deliver recombinant hBMP-2 and hOP-1 at sites of surgical implantation have several drawbacks, including the cost of the required high doses to induce and maintain a regenerated construct that may or may not be equal or superior to autogenous bone. 57Y59 To date, tissue engineering of bone has been approached in a rather crude single-morphogen approach and has resulted in uninspiring clinical performance at massive (and expensive) doses. The biologic evidence has demonstrated the benefits of binary morphogen applications to significantly and synergistically improve osteoinductive performance at remarkably lower doses. 6, 46, 49 Bone formation, whether during development or postnatal regeneration as in fracture repair, is the result of the concerted effects of many members coordinately expressed during the cascade of bone differentiation. 6, 20, 27 The presence of multiple molecular forms with bone-inductive activity points to several complex synergistic interactions during bone formation by induction. 6, 46, 49 Binary applications of recombinant hOP-1 together with relatively low doses of human TGF-A 1 synergize to induce massive ossicles in heterotopic sites of the nonhuman primate (P. ursinus) as early as 15 days after implantation. 49 Binary combinations should now be used in patients to avoid supraphysiologic doses of single recombinant proteins as currently required in clinical contexts.
53Y55,57Y59
Osteoinductive biomaterials obtained by combining molecular signals with insoluble substrata are now a reality of regenerative medicine after preclinical and clinical trials approved by regulatory agencies in Europe and North America for selected therapies in clinical contexts. 4Y6 The concept that optimal induction of bone formation is dependent on the combinatorial action of an osteogenic-soluble molecular signal, and a complementary substratum is of paramount importance for future therapeutic applications. 1, 5, 30, 60 This underscores the importance of carrier substrata as delivery systems for local application of the osteogenic-soluble molecular signals of the TGF-A superfamily. 5, 6, 30 In defining an osteoinductive biomaterial, it is important to differentiate it from an osteoconductive biomaterial. An osteoinductive biomaterial is one bearing osteogenic activity per se: Its discriminatory bioaction is osteogenesis. 60 An osteoconductive biomaterial, on the other hand, is not inherently osteoinductive: its function lies in its capacity to guide and direct the growth of bone at the interface into the biomaterial and to achieve osteointegration when implanted in intraskeletal orthotopic sites. 60 Against the above background, researchers and clinicians must start to consider several possible additive factors that may improve the clinical performance of bone tissue engineering. Among these are the smart biomimetic matrices that per se and without the exogenous applications of the OPs of the TGF-A supergene family initiate the induction of bone formation. 14, 19 Over and above the significant material properties of these matrices (which allow for the customization of large and complex shapes), the well-documented property of spontaneous osteoinduction may provide a biologic filling to clinical osteoinduction. Human osteoinduction will require the harnessing of many more concepts than are currently in use. Thus, whereas it is unlikely that smart biomimetic matrices will provide a solution when used ''solo'' in clinical contexts, the prospect that biomimetic matrices potentiate the inductive activity of OPs provides temporal and spatial control of morphogen desorption and direct cellular transformation that may solve several existing problems of bone tissue engineering. This is of particular interest to craniofacial surgeons who are tasked with the rehabilitation of the anatomically complex facial skeleton. In addition, the induction of bone formation in clinical contexts will have to be enhanced not only by the deployment of self-inductive biomimetic matrices but also by combining tissue-engineered transplants with stem cells 61, 62 mainly derived from myoblastic/myoendothelial and/or pericytic/endothelial cell populations. 63 The acid test for osteoinductivity is the histologic evidence of bone formation in extraskeletal heterotopic sites in animal models. 31 The necessity of having viable bone in direct contact with a porous biomaterial to ensure adequate bone ingrowth via osteoconduction is a limiting factor for regeneration, particularly in large bony defects, because the depth of bone penetration within the porous spaces may be confined to the peripheral regions of the implant only. 60, 64 Combining BMPs/OPs, and additionally in primates and the mammalian TGF-A isoforms, would obviate the disadvantages mentioned above because bone could form more rapidly, and importantly, bone would form by induction independent of the presence of viable bone at the interfaces of the implanted biomaterial. 60, 64 The potential therapeutic benefit that synthetic biocompatible substrata might have in controlling the osteogenic activity of BMPs/OPs has prompted the search for alternative delivery systems to the organic naturally derived collagenous matrices 65 from a number of donor animals including humans. Progress in identifying novel carriers has been hampered by a number of drawbacks inherent to the available range of biomaterials as alternative to the insoluble collagenous matrices. 6, 30, 48, 60 An ideal biomaterial for tissue engineering of bone should be nonimmunogenic and amenable to contouring for optimal adaptation to the various shapes of bone defects, providing mechanical support when needed. 60 Importantly, it should initiate osteogenesis with relatively low doses of recombinant hBMPs/hOPs promoting rapid vascular and mesenchymal cell invasion to be brought into contact with BMPs/OPs previously adsorbed and bound to the carrier. In addition, it should remodel and resorb once the regenerative processes are well under way. 6, 30, 48, 60 To date, biomaterials made of calcium phosphate/tricalcium phosphate apatites have been extensively tested in preclinical animal models and in clinical contexts.
66Y68 Phosphate/tricalcium phosphate apatites are all capable of osteoconduction to a varying degree; the addition of various ratios by weight of A-TCP to HAs (HA/A-TCP) adds the desirable characteristic of resorbability; HA/A-TCP biomatrices resorb to a varying degree through the process of osteoconduction and implant substitution. 60, 66, 67 An important feature of calcium phosphate biomatrices is their affinity for BMPs/OPs; this may reflect the in vivo supramolecular assembly of BMPs/OPs bound to both the extracellular matrix and the mineral components of the bone matrix. 4, 6, 60, 64 Importantly, the affinity of BMPs/OPs for HA is used in their chromatographic purification. 35, 38, 39 This affinity has been exploited for the construction of delivery systems following chromatographic adsorption of BMPs/OPs onto macroporous coral-derived HAs. This has resulted in osteogenic activity in extraskeletal sites of the nonhuman primate (P. ursinus). 6, 13 By exploiting the principle of centripetal fibrovascular ingrowth, macroporous HA and/or HA/A-TCP substrata are well suited for the formulation of delivery systems for the osteogenicsoluble molecular signals of the TGF-A superfamily. 6, 39, 60, 64, 65 The porous substratum of the implanted HA allowed a spatially controlled osteogenesis, restricting bone differentiation locally to surgical sites 6, 60, 64 ; the experiments also provided evidence that the biologic activity of BMPs/OPs could be restored and delivered by a substratum other than the collagenous matrix as carrier. 6, 65 Our laboratories have always assigned a prominent and pivotal role to the osteogenic-soluble molecular signals of the TGF-A supergene family; there is no bone formation by induction without BMPs/OPs or, in primates only, without the mammalian TGF-A isoforms 6, 45 ; however, we have always assigned additional critical roles to the biomimetism of specific matrices capable of delivering the biologic activity of the osteogenic-soluble molecular signals. 6 To initiate the induction of bone formation, osteogenic-soluble molecular signals need to be recombined or reconstituted with an insoluble signal or substratum to initiate bone differentiation by induction. 5, 6, 27, 29, 48 To initiate the induction of bone formation and thus to ultimately erect the skeleton, nature has had a powerful lesson to teach. A lesson that is continuously taught to biomaterial scientists, molecular biologists, and tissue engineers alike, who wish to design, manufacture, and sculpt new tissue constructs for replacement therapies in clinical contexts.
3Y7
Several advances in molecular biology and biomaterial science have led to the transition of biomaterials as providers of mechanical functions to molecularly more sophisticated biomaterials with attached biologic activities; these have been labeled smart biomimetic biomaterials mimicking nature's function and biologic activities. 7,9Y12,14 Our studies in the past several years have focused on the critical role of the geometry of the carrier substratum in the regulation of bone differentiation. Using geometric cues prepared in macroporous biomimetic bioceramics, we have provided evidence that tissue induction and morphogenesis can be greatly altered by the shape and geometry of the substratum.
12Y21
The insoluble signal or substratum that triggers biologic responses from the host tissues initiates vascular invasion and angiogenesis with capillary sprouting, culminating in osteogenesis. This angiogenic morphogenetic scenario is the highest priority in tissue engineering of bone, biomaterials science, and regenerative medicine alike. 
TAILORING MATRIX GEOMETRIES INTO BIOACTIVE BIOMIMETIC MATRICES TO SPONTANEOUSLY INITIATE THE INDUCTION OF BONE FORMATION
The basic tissue engineering paradigm is tissue induction and morphogenesis by combinatorial molecular protocols, whereby soluble molecular signals are combined with insoluble signals or substrata acting as three-dimensional scaffolds for the initiation of de novo tissue induction and morphogenesis. 3, 5, 26, 27 Our research hypothesis since the early 1990s has been to try to modify the paradigm in which the very insoluble signal or substratum resorbs via downstream molecular and cellular cascades that sculpt resorption pits and lacunae in the geometric form of concavities within the implanted biomimetic matrices. The sculpted concavities within the biomimetic matrices initiate bone differentiation by induction.
6,7,12Y19,21
Can we engineer bioactive biomimetic matrices that, in their own right, spontaneously induce bone formation without the addition of exogenously applied osteogenic-soluble molecular signals? The novel concept of bone tissue engineering is the induction of bone by smart biomimetic matrices that per se induce a desired and specific morphogenetic response from the host tissues without exogenously applied OPs of the TGF-A supergene family. 6,7,12Y17 Since the late 1980s and the early 1990s, our laboratories have performed a series of systematic studies whereby macroporous and solid biomimetic matrices of calcium phosphate bioceramics were implanted in heterotopic extraskeletal sites of the nonhuman primate (P. ursinus). 6, 7, 13 The morphogenesis of bone following heterotopic intramuscular implantation of coral-derived porous HAs has been instrumental for the biologic realization that certain macroporous constructs when implanted in heterotopic intramuscular sites of the nonhuman primate (P. ursinus) induce the spontaneous and/or ''intrinsic'' induction of bone formation within the macroporous spaces of the implanted bioceramic constructs. 64, 70, 71 This was followed by the development of sintered highly crystalline HAs culminating in the construction of smart biphasic HA/A-TCP constructs. 19, 21 The use of biomimetic matrices capable of initiating bone formation via intrinsic osteoinduction is fast altering the horizons of therapeutic osteogenesis leading to a quantum leap in bone tissue engineering. 60 The geometry of the substratum profoundly regulates the expression of the osteogenic phenotype. 6, 19, 65, 72 Our laboratories have defined the intrinsic induction of bone formation by macroporous bioceramic constructs as geometric induction of bone formation. 14 The intrinsic osteoinductivity regulated by the geometry of the substratum is helping to engineer morphogenetic responses for therapeutic osteogenesis in clinical contexts. 14 Several experiments in P. ursinus, in collaboration with the Materials Science & Manufacturing Technology Group of the Council for Scientific and Industrial Research, Pretoria, have shown that a specific geometry of the substratum of sintered highly crystalline HAs drives the morphogenesis of bone by induction within the macroporous constructs. 14, 15, 19, 21 We have found that the morphogenetic geometry has the shape of a concavity and that the concavity is smart because it binds and embeds specific BMPs/OPs gene products into the biomimetic matrix surfaced by resident responding myoblastic stem cells within the fibrovascular tissue invading the concavities of the bioceramic constructs. 12, 14, 15, 18, 19, 21 In collaboration with the Council for Scientific and Industrial Research, we have encapsulated repetitive sequences of concavities as biologically programmed morphogenetic cues into solid biomimetic matrices that result in the differentiation of resident mesenchymal myoblastic and/or pericytic stem cells into osteoblastic-like cells expressing, secreting, and embedding soluble osteogenic molecular signals into the smart concavities initiating the induction of bone formation as a secondary response. 14, 19, 21 Biomimetic matrices of highly crystalline HAs or HA/A-TCP biomimetic matrices have been constructed with geometric configurations that vividly reproduce and biomimetize the bone remodeling processes of primate osteonic bone. 13, 17, 19, 20 Remodeling entails resorption, that is, areas of trabeculae actively resorbed by activated osteoclasts. Importantly, the bone resorption lacunae as cut by osteoclastogenesis are in the form of concavities; the concavities are thus regulators of bone initiation and deposition during the remodeling processes of the primate skeleton. The described highly crystalline HAs and HA/A-TCP biomimetic matrices mimic the remodeling cycle of the bone unit or osteosome 72 in the form of resorption lacunae and pits cut by osteoclastogenesis later used for the deposition of bone formation by induction. 6,7,12Y17 The molecular paradigm of regenerative medicine and tissue engineering is the reconstitution of a soluble osteogenic molecular signal with an insoluble signal or substratum that delivers the osteogenic activity of the soluble molecular signal. 3, 5, 27 Our modified paradigm is one in which the very insoluble signal resorbs via a downstream of molecular and cellular cascades that sculpt resorption pits and lacunae in the geometric form of concavities within the implanted HA/A-TCP biomimetic matrices. 19, 21 The concavities sculpted within the implanted biomimetic matrices initiate bone differentiation by induction. 19, 21 The operational molecular and cellular resorption and dissolution of the implanted matrices sculpting lacunae and pits in the form of concavities are the biologic continuum for the induction of bone formation. 19, 21 There is thus a continuum between the soluble and the insoluble solid states of the newly formed bone as in the skeleton in which the continuum is regulated by signals in solution interacting with the insoluble signals of the extracellular matrix. 24 The advent of novel synthetic biomaterial matrices that per se intrinsically initiate the morphogenesis of bone is a great challenge for the design and development of bioactive biomimetic matrices for tissue engineering of bone in the absence of exogenously applied BMPs/OPs. 54, 55, 73 The versatile nature of these biomimetic biomaterials makes them more practical and more cost-effective in their clinical application than devices requiring the combination of both biomaterial matrices and DNA recombinantly produced hBMPs/ hOPs. 73 We now know that the specific geometric configuration in the form of repetitive concavities as prepared in the biomimetic matrices mimics nature's evolved antiquity of the remodeling cycle of the primate corticocancellous bone. 6, 7, 12, 13 The concavities are inducive and conducive to unique molecular and biologic microenvironments capable of differentiating myoblastic/myoendothelial and/or endothelial/pericytic stem cells into osteoblastic-like cells, initiating bone formation by induction as a secondary response.
19Y21
We now understand that there are more mechanisms that need to be unlocked to unravel the fascinating phenomenon of the geometric induction of bone formation. 14 
EMBEDDING MOLECULAR SIGNALS IN SMART BIOMIMETIC MATRICES TO SELF-INDUCE BONE TISSUE CONSTRUCTS IN ANGIOGENESIS:
A PICTORIAL VIEW
To convey the molecular, cellular, topographic, and geometric messages described above, the following figures are a digital iconographic pictorial view highlighting what it is that is known on the spontaneous induction of bone formation after extensive systematic studies in the nonhuman primate (P. ursinus) (Figs. 1Y8) . 6,7,12Y21,27,46,64,70,71,73 
THE CONCAVITYVA PROTECTED MICROENVIRONMENT FOR STEM CELL DIFFERENTIATION
The critical role of the concavity as morphogenetic cue initiating the induction of bone formation has been exhaustively documented by the iconographic digital images (Figs. 1Y8) . What is it that triggers the bone induction cascade? What is it about the concavities that per se set into motion the ripple-like cascade of bone differentiation by induction? We propose that the initiating mechanisms are 2-fold: First, mechanical distortions/stress 77, 78 are created by the topographical alteration in the geometrical structure of the concavities (Fig. 8) . The concavity, when in heterotopic intramuscular sites, creates a vacuum, forcing the surrounding tissue to invaginate. The invagination of mesenchymal/striated muscular tissue triggers specific receptors with associated changes in gene expression 77, 78 ; this regulates the migration of stem cells and angiogenesis. 77, 78 Second, morphologic analyses of biphasic HA/A-TCP biomimetic constructs have shown that osteoclastogenesis is also a prerequisite for the later induction of bone formation in a continuum of resorption/dissolution and induction of bone formation. 19, 21 Activated macrophages and osteoclasts attach and glide along the surface of the concavities resorbing/dissolving spiculae of calcium phosphate. Macrophage/osteoclastic topographical surface alterations lead to the release of calcium ions into the protected microenvironment of the concavity. The calcium ions retained within the concavities induce angiogenesis. 79Y81 Coupled to the mechanical distortion, 77, 78 angiogenesis will trigger the invasion FIGURE 1. Effects of the substratum of coral-derived macroporous HA biomatrices (Interpore) on tissue induction and morphogenesis within the porous spaces of the biomimetic matrices implanted heterotopically in the rectus abdominis muscle of P. ursinus. 60, 70, 73 A and B, Differentiation of osteoblastic-like cells at the HA interface highlighted in B. Osteogenetic vessels, as defined by Trueta, 74 penetrate the mesenchymal condensations seemingly providing migrating cellular progenitors (arrows in B). Pericytic progenitors provide osteoblastic cell differentiation when in contact with the HA substratum (arrows in A and B). C, Alkaline phosphatase staining of invading capillaries (arrows), the osteogenetic vessels, 74 within the macroporous spaces of the coral-derived HA construct. D and E, Undecalcified sections stained free-floating with a modified Goldner trichrome showing mineralization (arrows) within collagenous condensations (arrows) formed at the HA interface. Mineralized bone (arrows) is surfaced by osteoid seams populated by osteoblastic cells. F and G, Tissue morphogenesis and the spontaneous induction of bone formation within the macroporous spaces of coral-derived HA biomatrices implanted in the rectus abdominis muscle of P. ursinus. Bone induction within concavities (arrows) of the macroporous HA constructs. H, Undecalcified section of coral-derived macroporous HA showing the induction of mineralized newly formed bone (arrow) surfaced by osteoblastic-like cells. Mesenchymal collagenous condensations (arrows) had formed against the biomimetic substratum. I, Vascular invasion (arrow) with the induction of bone formation (arrow) within a concavity of an implant of particulate/granular coral-derived HA. Within the morphogenetic and molecular scenario of the several morphologies and geometries of the mammalian body, the concavity, as cut into the macroporous calcium phosphate construct, mimics the remodeling cycle of the primate osteonic bone. Concavities, as prepared into the biomimetic macroporous calcium phosphateYbased bioceramic constructs, biomimetize the concavities cut by osteoclastogenesis during the remodeling cycle of the corticocancellous bone. The concavity is the driving molecular and morphogenetic cue initiating the multistep molecular and cellular cascades leading to the induction of bone formation. Digital images in H and I were instrumental for the understanding of the role of the concavity as a morphogenetic cue for the ''spontaneous'' induction of bone formation.
14,19
Ripamonti
of myoblastic/myoendothelial and/or endothelial pericytic stem cells coming to rest in the protected microenvironment of the concavity. The free calcium ions that have accumulated in the concavity regulate stem cell differentiation into osteoblastic-like cells, 75, 76 secreting and embedding soluble osteogenic molecular signals within the smart concavities of the biomimetic matrices 63 initiating bone formation by autoinduction. 31 
CONCLUSIONS Challenges and Perspectives of Self-Inducing Biomimetic Matrices
Heterotopic bone induction in the nonhuman primate (P. ursinus) isinitiated by BMPs/OPs, the 3 mammalian TGF-A isoforms, and by biomimetic matrices of calcium phosphateYbased macroporous constructs. This indicates that the induction of heterotopic ossicles in the primate develops as a mosaic structure in which the osteogenic-soluble molecular signals of the TGF-A supergene family singly, synergistically, and coordinately initiate and maintain the developing morphologic structure and play different roles at different time points of the morphogenetic cascade. 6, 20 This is useful in defining skeletal regeneration and tissue morphogenesis in molecular terms. These findings imply a surprisingly simple and fascinating concept: morphogens exploited in embryonic development can be reexploited and redeployed for the initiation of postnatal morphogenesis and regeneration. 6, 46 More importantly, for many countries around the world, this research is directed to continuously improve the intrinsic osteoinductivity of biomimetic biomaterial matrices whereby the implanted patients are providing their own locally expressed and secreted osteogenic gene products to be embedded into the smart biomimetic matrices; this initiates the induction of bone formation without the exogenous application of expensive megadoses of recombinant hBMPs/hOPs. 45 Continuous advances in the realm of molecular and cellular biology, tissue biology, and experimental surgery have allowed a previously unknown biologic knowledge of the cellular and molecular mechanisms of growth, differentiation, development, and morphogenesis of vertebrate tissues and organs. 5Y7,26 This explosive knowledge of tissue biology blended several different but linked scientific disciplines into the emerging science of tissue engineering. 1Y3,5,25 Regenerative medicine and tissue engineering merge molecular, cellular, and developmental biology with the science of biomaterials and experimental surgery. 5, 25 Tissue engineering has made possible 70,73 AYC, Substantial regeneration of bone across the porous spaces of the coral-derived constructs harvested on day 90 after calvarial implantation. D and E, Significant induction of bone formation within the macroporous spaces of coral-derived, fully converted HAs; remodeling and maintenance of the induced bone across the coral-derived macroporous scaffolds 280 days after calvarial implantation in the adult baboon (P. ursinus).
the interdisciplinary challenge to construct new tissues and organs to restore impaired tissues and to regenerate lost parts of the human body.
1Y3,5Y7 Pluripotent stem cells harvested from ''niches'' within the mammalian body additionally provide novel insights into bone tissue engineering and regenerative medicine. 61, 62 The topography of the extracellular matrix substrata and of biomimetic matrices regulates cell migration and the induction of cellular phenotypes constructing tissue morphogenesis in angiogenesis. 63 Our research results propose that concavities cut within extracellular matrix substrata provide a morphogenetic microenvironment in which myoblastic/myoendothelial and/or endothelial/pericytic stem cells migrate and attach to the substratum, eventually differentiating into secreting osteoblastic-like cells under the influence of released calcium ions together with angiogenesis and capillary sprouting. 63 Our laboratory has set out to modify the basic tissue engineering paradigm by creating biomimetic matrices that per se initiate the differentiation of resident stem cells expressing, secreting, and embedding selected gene products of the OPs of the TGF-A superfamily. The smart biomimetic matrices initiate the ripple-like cascade of bone differentiation by induction as a secondary response. 14, 19, 21 The final leap into the intrinsic induction of bone formation will necessitate the mechanistic understanding of how the microstructured surface area of calcium phosphate biomaterial matrices differentiates inducible stem cells into osteoblastic-like cells expressing osteogenic-soluble molecular signals. 19 The protected microenvironment of the concavity releasing calcium ions together with mechanical distortions on the selected invading fibrovascular tissue with stem cells results in angiogenesis, capillary sprouting, and cellular differentiation into osteoblastic cell lines. 75,76,79Y81 Our latest studies have shown that osteoclastic postimplantation modifications of the implanted macroporous constructs are critical for the induction of micropatterned and macropatterned self-initiating topographies. 63 Osteoclastic patterned topographies differentiate resident stem cells into osteoblastic-like cells expressing the osteogenic-soluble molecular signals of the TGF-A supergene family. 63 Indeed, zoledronate-treated macroporous constructs showed limited if any bone formation as a result of osteoclastic inhibition; qRT-PCR also showed a significant reduction of OP-1 gene expression. 63 The latter findings also confirm that the spontaneous induction of bone formation is initiated by secreted BMPs/OPs, in context the OP-1 isoform. 63 Despite the isolation and molecular cloning of the OPs of the TGF-A supergene family, bone tissue engineering in clinical contexts has proven to be elusive because of the very high quantities of required human recombinant morphogens yielding uninspiring amounts of newly induced bone, occasionally comparatively lower than autogenous bone grafts. 26 ,57Y59 Preclinical results obtained Complete calvarial regeneration with resorption/dissolution of the implanted biomimetic matrix replaced in toto by newly formed bone by induction. ; implantation of high doses of recombinant hBMPs/hOPs has often been punctuated by the lack of total and/or convincing regeneration so often needed in unfavorable clinical settings 57Y59 Implantation of high doses of recombinant hBMP-2 (up to 24 mg) failed to regenerate substantial mandibular defects in human patients. 82 The variable results obtained in human patients after implantation of high doses of recombinant hBMPs/hOPs have necessitated a new definition for the induction of bone formation in clinical contexts, that is, the concept of ''clinically significant osteoinduction.'' We propose to define clinically significant osteoinduction as the quantity of regenerated bone adequate to be identified FIGURE 6. Biomimetism of the concavity induced by osteoclastogenesis during the remodeling cycle of the osteonic bone with the induction of bone formation by porous biomimetic substrata even when implanted in heterotopic extraskeletal sites and without the addition of exogenously applied OPs of the TGF-A supergene family. A and B, Sculpted concavities by remodeling cycles in ancient hominid skeletal fossilized remains of corticocancellous bone of Australopithecus africanus, the man ape of Southern Africa, temporally confined on faunal and paleomagnetic grounds to 2.5 to 3 million years before the present. 19 Arrows indicate the extent of osteoclastic activity within the trabecular bone of the extinct hominid fossilized specimen; arrows point to calcite crystals occupying the cancellous spaces of the fossilized corticocancellous remains of A. africanus. C and D, Corticocancellous bone remodeling and osteoclastogenesis (arrows) in extant nonhuman primates (P. ursinus). Concavities induced by osteoclastogenesis along trabeculae of bone biomimetize the concavities prepared in biomimetic bioceramics setting formation after resorption (arrows in D and E). F, Self-inducing concavities initiating the spontaneous induction of bone formation (arrows) in biomimetic matrices when implanted in heterotopic extraskeletal sites of an adult baboon (P. ursinus). F, Arrows indicate the rich vascular network and capillary sprouting that always correlate with the induction of bone formation within the macroporous biomimetic matrices. FIGURE 7. Self-inducing geometric cues: the concavity and the induction of bone formation by sintered highly crystalline solid macroporous HA constructs implanted heterotopically in the rectus abdominis muscle of P. ursinus. A, Induction of bone within repetitive concavities (arrows) of a macroporous sintered HA construct on day 30 after implantation in the rectus abdominis muscle. The induction of bone formation within the concavities of the highly crystalline sintered constructs was instrumental for the preparation and testing of solid disks of highly crystalline HA (B) with concavities on both planar surfaces. C, The spontaneous induction of bone formation (arrows) without the addition of osteogenic-soluble molecular signals initiates on day 30 within a concavity of a highly crystalline sintered HA implanted in the rectus abdominis muscle of adult baboons. D, Remodeling and further bone differentiation surfaced by multiple contiguous osteoblasts (arrows) within a concavity of the biomimetic matrix on day 90 after heterotopic intramuscular implantation. EYG, Morphogenesis of bone within the macroporous spaces of highly crystalline HA biomatrices together with prominent vascular invasion and bone remodeling on day 90 after intramuscular implantation. Our research hypothesis as illustrated in panels A, C, and D is that resident myoblastic/myoendothelial and or endothelial/pericytic stem cells attached to the biomimetic matrix undergo transformation within the highly morphogenetic microenvironment of the concavity including the penetrating osteogenetic vessels and the highly mineralized matrix releasing calcium ions critical for angiogenesis and the differentiation of osteoblastic-like cells. 63, 75, 76 radiographically as normal bone in radiolucency and trabecular architecture.
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Developing second-generation recombinant hBMPs/hOPs is currently an exciting and important area of future research. 83, 84 Genetic engineering is aimed at improving potency by producing BMP/OP heterodimers resulting in more potent bone-inducing activity. 83 Improving recombinant hBMP/hOP processing and stability is another area of fertile research together with designing recombinant hBMPs/hOPs with decreased affinity to Noggin. 83 All of the above should result in novel recombinant hOPs with enhanced morphogenetic and bone-inductive activity at lower doses than the available recombinant proteins. 83, 84 An important challenge for the future of tissue engineering in clinical contexts is the development and testing in human patients of biomimetic matrices that per se direct cell differentiation with expression of selected mRNA species of the TGF-A supergene family where the induction of bone is initiated even in the absence of endogenously applied OPs of the TGF-A supergene family. Biomimetic matrices of highly crystalline or biphasic HA/A-TCP constructed with a series of repetitive concavities offer a geometric configuration that vividly reproduces and biomimetizes the remodeling process of the primate osteonic bone. Osteoinductive bioceramics prepared with selected surface microporosity primed either by osteoclastic surface configurations 63 or by specific physiochemical structural characteristics 85 induce stem cell differentiation, BMP/OP synthesis and expression, and bone formation as a secondary response. Implantation in a large bone defect in sheep unequivocally demonstrated the concept that osteoinductive bioceramics are equally efficient in bone repair as autologous bone grafts. 85 Currently, the concept of the spontaneous and/or intrinsic induction of bone formation is a scientific curiosity rather than a clinical reality, and further development is required to address several challenges. The most significant of these is optimization of the mutually exclusive properties of matrix resorption and physical characteristics. A matrix with adequate rigidity is endowed with excessively slow resorption time, which is a major impediment to the ultimate goal of ''restitutio ad integrum.'' Fast-resorbing matrices are brittle and fail to provide an environment suitable for meaningful bone induction in humans. Nevertheless, it is an avenue of research that deserves further attention for the problem of bone regeneration that still remains to be solved.
The geometric assembly of a series of repetitive concavities within macroporous biomimetic matrices mimics nature's design; the assembly of concavities within macroporous constructs is learning from nature how to design smart intelligent biomimetic matrices for tissue induction and morphogenesis. Research data in the nonhuman primate (P. ursinus) have shown that the role of molecularly designed biomimetic matrices in regenerative medicine is guided by the biomimetism of the extracellular matrix. 19 The geometric design of the biomimetic matrix sets into motion the ripple-like cascade of tissue induction and morphogenesis initiating the induction of bone formation. The future of bone tissue engineering is thus to construct biomimetic matrices to predictably induce bone formation by autoinduction. 31 FIGURE 8. The remodeling cycle of the primate corticocancellous bone biomimetizes the induction of bone formation in concavities as carved into heterotopically implanted biomimetic matrices. Topographical modification of the implanted macroporous surfaces by osteoclastogenesis results in Ca 2+ release within the concavity microenvironment. The concavity provides a sheltered microenvironment which allows for a calcium concentration spike within the concavity. This stimulates cellular differentiation and angiogenesis. Ca 
